当前位置:首页 - 行情中心 - 泽璟制药-U(688266) - 财务分析

泽璟制药-U

(688266)

  

流通市值:283.77亿  总市值:283.77亿
流通股本:2.65亿   总股本:2.65亿

泽璟制药-U(688266)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润-0.76亿元,每股收益-0.28元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益117661.54万元,未分配利润-218954.60万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产299920.34万元,负债182258.79万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入375,650,273.55167,641,962.39532,954,371.3384,117,191.62
营业总成本475,168,324.66224,891,718.58726,897,941.91509,620,185.43
其他经营收益
营业利润-76,731,169.28-30,017,022.32-155,043,183.78-112,548,101.52
利润总额-77,414,988.02-30,317,022.32-155,047,806.79-112,602,724.53
净利润-75,569,945.5-29,313,362.27-150,298,322.91-109,646,565.01
每股收益
其他综合收益-477,198.95140,191.46-8,749,199.6926,035,078.95
综合收益总额-76,047,144.45-29,173,170.81-159,047,522.6-83,611,486.06
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计2,551,629,069.42,496,560,281.492,575,898,809.82,565,243,592.54
非流动资产:
非流动资产合计447,574,282.64421,263,599.42428,715,474.18401,904,317.46
资产总计2,999,203,352.042,917,823,880.913,004,614,283.982,967,147,910
流动负债:
流动负债合计1,342,223,646.41,325,481,564.641,373,445,525.831,313,676,788.18
非流动负债:
非流动负债合计480,364,269.2368,612,453.87378,568,209.03350,665,123.57
负债合计1,822,587,915.61,694,094,018.511,752,013,734.861,664,341,911.75
所有者权益(或股东权益):
归属于母公司股东权益合计1,176,615,436.441,226,013,046.531,253,857,931.481,303,387,496.25
股东权益合计1,176,615,436.441,223,729,862.41,252,600,549.121,302,805,998.25
负债和股东权益合计2,999,203,352.042,917,823,880.913,004,614,283.982,967,147,910
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计475,143,193.87216,781,433.79872,829,012.32702,864,034.36
经营活动现金流出小计492,163,469.95223,034,586.21834,624,467.53636,216,963.79
经营活动产生的现金流量净额-17,020,276.08-6,253,152.4238,204,544.7966,647,070.57
投资活动产生的现金流量:
投资活动现金流入小计17,373,2007,177,4001,217,088,569.191,016,865,822.15
投资活动现金流出小计79,715,800.3633,808,123.123,062,189,956.331,008,410,550.44
投资活动产生的现金流量净额-62,342,600.36-26,630,723.12-1,845,101,387.148,455,271.71
筹资活动产生的现金流量:
筹资活动现金流入小计431,521,145.08141,321,903.341,288,618,503.6798,000,000
筹资活动现金流出小计405,608,309.59173,118,011.281,339,934,919.14876,125,567.19
筹资活动产生的现金流量净额25,912,835.49-31,796,107.94-51,316,415.54-78,125,567.19
汇率变动对现金及现金等价物的影响-453,654.23-9,211.92-2,298,440.51-536,724.67
现金及现金等价物净增加额-53,903,695.18-64,689,195.4-1,860,511,698.4-3,559,949.58
期末现金及现金等价物余额163,361,797.9152,576,297.68217,265,493.082,074,217,241.9
补充资料:
现金及现金等价物的净增加额-53,903,695.18--1,860,511,698.4-
最新报告期:2025-08-28
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华安证券谭国超0.272.003.862025-08-28
西部证券李梦园-0.200.631.592025-08-26
野村东方国际证券孔令岩,肖鸿德-0.220.641.752025-08-25
西南证券杜向阳,汤泰萌-0.200.882.352025-08-25
国联民生夏禹,郑薇-0.230.691.162025-08-23
TOP↑